News

A scientific revolution is underway as researchers push to bring atomic-level precision, once reserved for small molecule ...
Historically, small molecule drugs have been precisely designed down to the atomic scale. Considering their relatively large complex structures, nanomedicines have lagged behind. Researchers argue ...
Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level. The ...
A joint research team has developed a modular protein adapter technology that enables the stable attachment of various ...
With a 90Hz refresh rate and nano-etched anti-glare screen, users can enjoy an eye-friendly and smooth visual experience ...
Imagine tiny LEGO pieces that automatically snap together to form a strong, flat sheet. Then, scientists add special chemical "hooks" to these sheets ...
Marama Labs has launched its CloudSpec instrument for nanomedicine development, which is expected to cut time and speed up ...
Gut Microbiota in Immuno-Oncology: A Practical Guide for Medical Oncologists With a Focus on Antibiotics Stewardship Bispecific antibodies (bsAbs) have emerged as a novel class of therapeutics, ...
Credit: Dalin Ou via Getty Images. US biotech Merida Biosciences has launched with $121m in Series A financing to develop therapeutics targeting disease-causing antibodies in autoimmune diseases and ...
Global pharmaceutical stocks plunged on the news Wednesday, with U.K.-based AstraZeneca dropping 5% and Swiss drugmaker Novartis losing 3% in early trading on U.S. exchanges. Top U.S. drugmakers, ...
FNAIT is a condition where maternal antibodies, formed against a fetal platelet antigen inherited from the father, cross the placenta and destroy fetal platelets. This leads to thrombocytopenia ...